Assignee
RECURSION PHARMACEUTICALS INC
US·34 granted patents·39 pending applications·37 citations·filing 2018–2025
Top patents by PatentIndex Score
73 records- 0191US10146914B1Systems and methods for evaluating whether perturbations discriminate an on target effectRECURSION PHARMACEUTICALS INC·Filed 2018·Granted Dec 4, 2018·17 cites·28 claims
- 0290US11791019B2Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2022·Granted Oct 17, 2023·1 cites·15 claims
- 0388US12119090B1Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddingsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Oct 15, 2024·4 cites·20 claims
- 0488US2024387003A1Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0587US11705223B2Preemptible-based scaffold hoppingRECURSION PHARMACEUTICALS INC·Filed 2022·Granted Jul 18, 2023·1 cites·14 claims
- 0686US11919868B2Heterocyclic compounds and related methodsRECURSION PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·24 claims
- 0785US12119091B1Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddingsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Oct 15, 2024·2 cites·20 claims
- 0885US2024029832A1Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0984US2025095392A1Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacyRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1084US2025095146A1Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacyRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1183US12073638B1Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacyRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Aug 27, 2024·0 cites·20 claims
- 1282US12079992B1Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacyRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 1382US10281456B1Systems and methods for discriminating effects on targetsRECURSION PHARMACEUTICALS INC·Filed 2018·Granted May 7, 2019·4 cites·30 claims
- 1481US2025322917A1Utilizing flow measures of a generative stochastic model and action values of an action-value model to generate structural representationsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1579US11393560B2Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2018·Granted Jul 19, 2022·2 cites·22 claims
- 1679US11361438B2Techniques for analyzing and detecting executional artifacts in microwell platesRECURSION PHARMACEUTICALS INC·Filed 2020·Granted Jun 14, 2022·2 cites·20 claims
- 1779US2025078976A1Systems and methods for evaluating query perturbationsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1878US12300360B2Preemptible-based scaffold hoppingRECURSION PHARMACEUTICALS INC·Filed 2024·Granted May 13, 2025·0 cites·19 claims
- 1977US12374429B1Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfacesRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Jul 29, 2025·0 cites·20 claims
- 2077US11715551B2Systems and methods for evaluating query perturbationsRECURSION PHARMACEUTICALS INC·Filed 2020·Granted Aug 1, 2023·1 cites·21 claims
- 2176US2025342912A1Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfacesRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2276US2026066039A1Training and using generative thermodynamics neural networks to determine binding affinities from energy distributionsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2376US2025201351A1Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddingsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2475US11501853B2Preemptible-based scaffold hoppingRECURSION PHARMACEUTICALS INC·Filed 2020·Granted Nov 15, 2022·1 cites·18 claims
- 2574US12170135B2Systems and methods for evaluating query perturbationsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Dec 17, 2024·0 cites·22 claims
- 2674US12014804B2Preemptible-based scaffold hoppingRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Jun 18, 2024·0 cites·17 claims
- 2772US12528779B2Heterocyclic compounds and related methodsRECURSION PHARMACEUTICALS INC·Filed 2024·Granted Jan 20, 2026·0 cites·9 claims
- 2872US2026088138A1Active learning using coverage scoreRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2971US10743109B1Ordered picklist for liquid transferRECURSION PHARMACEUTICALS INC·Filed 2020·Granted Aug 11, 2020·1 cites·21 claims
- 3071US2025225161A1Utilizing language machine learning models for autonomous executions of computerized tech-bio exploration toolsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3171US2025225126A1Utilizing language machine learning models for autonomous executions of computerized tech-bio exploration toolsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3270US2025391518A1Training and utilizing compound graph neural networks to generate biological activity predictions from input chemical compoundsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3370US2026038647A1Utilizing compound-protein machine learning representations to generate bioactivity predictionsRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3469US12525324B2Active learning using coverage scoreRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Jan 13, 2026·0 cites·20 claims
- 3569US11612134B1Electronic monitor for experimental animalsRECURSION PHARMACEUTICALS INC·Filed 2021·Granted Mar 28, 2023·0 cites·20 claims
- 3669US2025342591A1Training and utilizing machine learning models to generate perturbation embeddings from phenomic images of cells, including neuronal cell imagesRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3768US12373950B1Training and utilizing machine learning models to generate perturbation embeddings from phenomic images of cells, including neuronal cell imagesRECURSION PHARMACEUTICALS INC·Filed 2025·Granted Jul 29, 2025·0 cites·20 claims
- 3867US12533356B2Pyrazolopyrimidine compounds as adenosine receptor antagonistsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Jan 27, 2026·0 cites·12 claims
- 3967US12462903B2Utilizing compound-protein machine learning representations to generate bioactivity predictionsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 4067US2026024614A1Utilizing a clinical-phenomics causal discovery framework to generate causal discovery predictionsRECURSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4165US12494266B1Utilizing a clinical-phenomics causal discovery framework to generate causal discovery predictionsRECURSION PHARMACEUTICALS INC·Filed 2024·Granted Dec 9, 2025·0 cites·20 claims
- 4264US12009064B2Systems and methods for high throughput compound library creationRECURSION PHARMACEUTICALS INC·Filed 2019·Granted Jun 11, 2024·0 cites·20 claims
- 4364US2025225321A1Generating large-language-model compatible sequential attachment-based fragment embedding molecular representationsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4464US2025225377A1Generating large-language-model compatible sequential attachment-based fragment embedding molecular representationsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4563US11109801B2Method of measuring efficacy of treatment for an autoimmune disease in vivarium animalsRECURSION PHARMACEUTICALS INC·Filed 2019·Granted Sep 7, 2021·0 cites·3 claims
- 4663US2025391515A1Determining phenomic relationships between compounds and cell perturbations utilizing machine learning modelsRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4762US2025356944A1Generating a mechanism of action representation from cell representation embeddings to predict a mechanism of action for a perturbationRECURSION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4860US2024092770A1Heterocycle RMB39 ModulatorsRECURSION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4959US12462899B2Utilizing compound-protein machine learning representations to generate bioactivity predictionsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 5057US12540149B2Aromatic heterocyclic compound, pharmaceutical composition, and use thereofRECURSION PHARMACEUTICALS INC·Filed 2021·Granted Feb 3, 2026·0 cites·3 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when RECURSION PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →